Cargando…

Lurasidone-induced Parkinsonism and Hyperprolactinemia

Detalles Bibliográficos
Autores principales:	Suthar, Navratan, Aneja, Jitender
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436398/ https://www.ncbi.nlm.nih.gov/pubmed/30983673 http://dx.doi.org/10.4103/IJPSYM.IJPSYM_274_18

Ejemplares similares

Lurasidone-induced Oculogyric Crisis
por: Das, Soumitra, et al.
Publicado: (2017)

Fluoxetine-induced pseudocyesis in a patient with obsessive-compulsive disorder: A case report
por: Nebhinani, Naresh, et al.
Publicado: (2018)

Fetishistic transvestism with ectodermal dysplasia: A case report
por: Rohilla, Jitendra, et al.
Publicado: (2019)

Neuropsychiatric Symptoms as Early Manifestation of Progressive Supranuclear Palsy
por: Suthar, Navratan, et al.
Publicado: (2018)

Frequency of anticardiolipin Ac in patients with hyperprolactinemia
por: Leães, Carolina G. S., et al.
Publicado: (2011)

Hyperprolactinemia: An often missed cause of male infertility
por: Singh, Pratibha, et al.
Publicado: (2011)

Severe Extrapyramidal Syndrome Caused by Lurasidone Low Dose
por: Das, Soumitra, et al.
Publicado: (2018)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Severe Hyperprolactinemia during Lurasidone Treatment in a 16-year Old Girl with Schizophrenia – A Case Report
por: Gjessing Jensen, Karsten
Publicado: (2022)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Reply to: Hyperprolactinemia and Hirsutism in Patients without Polycystic Ovary Syndrome
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
por: Hsu, Rai-Hseng, et al.
Publicado: (2023)

Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone
por: Nagamine, Takahiko, et al.
Publicado: (2023)

Pregabalin Use/Misuse: A Source of Consternation in Western Punjab
por: Aneja, Jitender, et al.
Publicado: (2022)

Developmental Delay, Hyperactivity and Mania: A Perfect Blend of Confusion in a Preschool Child
por: Kuppili, Pooja P., et al.
Publicado: (2019)

Pseudothrombocytopenia in a patient with bipolar type 2 disorder on lurasidone: A case report
por: Sakhardande, Kasturi Atmaram, et al.
Publicado: (2022)

Hyperprolactinemia with normal serum prolactin: “Hook effect” a concern in laboratory medicine aspect
por: Wiwanitkit, Viroj
Publicado: (2010)

Comments on “a comparative study of sexual behavior, dysfunction, satisfaction, relationship, and sexual quality of life among treatment naïve and abstinent men (buprenorphine maintained) with opioid (heroin) dependence syndrome”
por: Singh, Gurvinder P., et al.
Publicado: (2023)

Drug Induced Hyperprolactinemia
por: Venkatanarasu, Ashok, et al.
Publicado: (2021)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Steroid-responsive Encephalopathy as a Semblance of Neuroleptic Malignant Syndrome in a Patient with Schizophrenia
por: Aneja, Jitender, et al.
Publicado: (2019)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

Lurasidone hydrochloride
por: Zhang, Hua, et al.
Publicado: (2012)

Chlorpromazine-Induced Hyperprolactinemia on Rat’s Uterus
por: Zamani, Zahra, et al.
Publicado: (2015)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Lurasidone-induced mania: A case report
por: Fernández, T., et al.
Publicado: (2022)

Pharmacological causes of hyperprolactinemia
por: Torre, Daria La, et al.
Publicado: (2007)

Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia
por: Almazrouei, Raya, et al.
Publicado: (2021)

Oculogyric crisis with atypical antipsychotics: A case series
por: Nebhinani, Naresh, et al.
Publicado: (2017)

Sleeping Beauty Syndrome: A Case Report and Review of Female Cases Reported from India
por: Nebhinani, Naresh, et al.
Publicado: (2017)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Lurasidone in treatment of manic episode
por: Sánchez-Rivero, I.
Publicado: (2022)

Olanzapine-Induced Hyperprolactinemia: Two Case Reports
por: Barata, Pedro Cabral, et al.
Publicado: (2019)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach
por: Levine, Samara, et al.
Publicado: (2018)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Lurasidone-induced anemia: Is there a need for hematological monitoring?
por: Kirpekar, Vivek C., et al.
Publicado: (2019)

Risperidone-induced retrograde ejaculation and lurasidone may be the alternative
por: Shanmugasundaram, Natarajan, et al.
Publicado: (2019)

Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
por: Rafi, Mohammad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nv1rruu7hiv81jcq9bhr3q1pb4